David Charytan, MD, MSc, of NYU Grossman School of Medicine, discusses the two most important risk factors when assessing patients with autosomal-dominant polycystic kidney disease. (0:43 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback